Literature DB >> 1968379

The influence of thyroid hormone status on the hypothalamo-hypophyseal growth hormone axis.

P M Jones1, J M Burrin, M A Ghatei, D J O'Halloran, S Legon, S R Bloom.   

Abstract

Growth hormone (GH) synthesis is known to be impaired by either abnormally high or low levels of thyroid hormone. To determine the effects of these conditions on the central regulation of GH secretion, we have examined their effects on the hypothalamic regulatory peptides GH-releasing hormone (GH-RH) and somatostatin (SRIF). In thyroidectomized rat hypothalamus, a dramatic increase in GH-RH mRNA occurred in parallel with a decrease in peptide content. The significance of this phenomenon is uncertain and might possibly reflect some posttranscriptional derangement of GH-RH synthesis or an increased rate of GH-RH synthesis and release. In the hyperthyroid group, GH-RH showed significant decreases in both peptide and mRNA levels that might possibly reflect a decrease in GH-RH synthesis and secretion. No change was observed in SRIF peptide or mRNA levels in either thyroidectomized or T4-treated animals. As expected, GH mRNA levels in the anterior pituitary were dramatically decreased by thyroidectomy and unaffected by T4 treatment. In addition, in thyroidectomized pituitaries, the mature GH mRNA was observed to alter its structure, increasing in size by approximately 100 nucleotides. This increase in size was found to result from an increase in poly(A) tail length, the significance of which is as yet unclear.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968379     DOI: 10.1210/endo-126-3-1374

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.

Authors:  S O Nascif; M H Senger; J C Ramos-Dias; A M J Lengyel
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

Review 2.  Thyroid hormones and growth hormone secretion.

Authors:  R Valcavi; M Zini; I Portioli
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

3.  Posttranscriptional regulation of rat growth hormone gene expression: increased message stability and nuclear polyadenylation accompany thyroid hormone depletion.

Authors:  D Murphy; K Pardy; V Seah; D Carter
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 4.  Molecular biology of the regulation of hypothalamic hormones.

Authors:  J M Rondeel; I M Jackson
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

5.  PITX2 AND PITX1 regulate thyrotroph function and response to hypothyroidism.

Authors:  F Castinetti; M L Brinkmeier; D F Gordon; K R Vella; J M Kerr; A H Mortensen; A Hollenberg; T Brue; E C Ridgway; S A Camper
Journal:  Mol Endocrinol       Date:  2011-09-29

6.  Thyroid hormone modulation of the hypothalamic growth hormone (GH)-releasing factor-pituitary GH axis in the rat.

Authors:  N Miki; M Ono; N Hizuka; T Aoki; H Demura
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment.

Authors:  Patricia Molica; Sergio Oliva Nascif; Silvia Regina Correa-Silva; Larissa Bianca Paiva Cunha de Sá; José Gilberto Henriques Vieira; Ana-Maria Judith Lengyel
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

Review 8.  Neuroendocrine regulation of thyrotropin-releasing hormone (TRH) in the tuberoinfundibular system.

Authors:  R Toni; R M Lechan
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

9.  Decrease in hypothalamic vasopressin mRNA poly(A) tail length following physiological stimulation.

Authors:  K F Chooi; D A Carter; D Murphy
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

10.  Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.

Authors:  Sergio Oliva Nascif; Silvia Regina Correa-Silva; Marcos Roberto Silva; Ana-Maria Judith Lengyel
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.